Apogen Biotechnologies develops and commercializes therapies targeting drivers of cancer genomic mutation.
Business Model:
Revenue: $3M
Employees: 11-50
Address: 2815 Eastlake Avenue East
City: Seattle
State: WA
Zip: 98102
Country: US
Apogen Biotechnologies develops and commercializes therapies targeting drivers of cancer genomic mutation.
Contact Phone:
+12069577300
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2018 | Series A | 1 | $4M |
M Ventures M Ventures |
12/2016 | Series A | 9 | $7M |
AbbVie Biotech Ventures Accelerator Corp. Alexandria Venture ARCH Venture Partners Eli Lilly Johnson &a; Johnson Innovation Washington Research Foundation Watson Fund WuXi AppTec AbbVie Biotech Ventures Accelerator Corp. Alexandria Venture ARCH Venture Partners Eli Lilly Johnson &a; Johnson Innovation Washington Research Foundation Watson Fund WuXi AppTec |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|